Cargando…
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
BACKGROUND: To investigate the clinical impact of sarcopenia and skeletal muscle density (SMD) among patients with metastatic pancreatic adenocarcinoma who underwent palliative first line gemcitabine-based chemotherapy. METHODS: A total of 330 patients treated with first line gemcitabine-based chemo...
Autores principales: | Kim, In-Ho, Choi, Moon Hyung, Lee, In Seok, Hong, Tae Ho, Lee, Myung Ah. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814715/ https://www.ncbi.nlm.nih.gov/pubmed/33461517 http://dx.doi.org/10.1186/s12885-020-07753-w |
Ejemplares similares
-
Preoperative sarcopenia and post‐operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer
por: Choi, Moon Hyung, et al.
Publicado: (2018) -
Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2019) -
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
por: Choi, Younak, et al.
Publicado: (2015) -
Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy
por: Chan, Miu Yee, et al.
Publicado: (2019) -
New Skeletal Muscle Mass Index in Diagnosis of Sarcopenia
por: Moon, Jeong Jae, et al.
Publicado: (2018)